Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taspoglutide for cardiovascular outcomes in type 2 diabetes
NCT01018173Phase 3Completed
- Sponsor
- Roche
- Start
- Jan 2010
- Primary completion
- Jan 2011
- Modality
- Peptides
- Countries
- 25
01
Overview
A Phase 3 trial of taspoglutide in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started Jan 2010; status: completed.
02
Drugs
taspoglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01018173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01018173.